Whether this protective effect of osteoblasts on CML (stem) cells is mediated via factors influencing (stabilizing) the BRD4‐MYC pathway remains unknown. The gene discussed is MYC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.